Skip to main content
. 2023 Feb 21;73(728):e164–e175. doi: 10.3399/BJGP.2022.0298

Table 2.

Overview of responses to surveys and interviews by practice

Practice Eligible practice HCPs,a n Baseline survey responses October 2019, n (of those, prescribers, n) 2-month follow-up survey responses December 2019, n (of those, prescribers, n) Interviews February/March 2020, n (job title) Interviews October/November 2020, n (job title)
A 4 3 (2) 2 (1) 1 (nurse) 1 (GP)
B 10 8 (3) 10 (3) 1 (GP) 0
C 5 5 (5) 3 (3) 2 (GP) 1 (GP)
D 9 7 (1) 8 (2) 0 1 (GP)
E 13 13 (11) 12 (10) 0 1 (GP)b
F 14 11 (5) 7 (3) 2 (ambulatory clinician and GP) 1 (GP)
G 7 6 (3) 5 (3) 1 (GP) 1 (GP)
H 11 5 (5) 5 (5) 0 1 (GP)b
J 8 8 (4) 9 (5) 2 (GP)b 1 (GP)
Total 81 67c (39) 62c (35) 9 8
a

The number of eligible HCPs in practices changed over the duration of the study. Numbers shown were as reported by practice contacts at baseline.

b

One interview with a clinician who was not the antibiotic champion.

c

One responder did not identify which practice they were from. HCPs = healthcare professionals.